Current UK guidance suggests women should wait for 12 weeks after they have given birth to be screened
The initiative is hoped to contribute towards wider efforts to increase visibility and awareness of the importance of breast screening
Endometrial cancer is the sixth most common cancer in women worldwide
The new panel is designed to identify women who are diagnosed with ER+ breast cancer but do not respond to hormone therapy
Israeli researchers tested the new drug and achieved a survival rate of 80 per cent
The programme is aimed at restoring ovarian function, addressing the root cause of the symptoms
The London-based company aims to help combat late-stage cancers using proprietary technology
The system would provide clinicians with a suite of AI tools and applications to advance the diagnostic experience
If successful, the drug could become the first ever non-hormonal and non-surgical treatment for endometriosis
The breast cancer screening pod has been installed at Queen Elizabeth Hospital in Gateshead
